Patient preferences for pharmaceutical and interventional hypertension treatments: results from a discrete choice experiment

Among U.S. patients with HTN, a DCE study demonstrated that BP reduction was the most important driver of choice, risks were less important, and a minimal BP reduction was sufficient to offset treatment risks associated with an interventional procedure like RDN.